E-LIB Suche - Ergebnisse für: Mallinckrodt, C

1

"Time Saved" Calculations to Improve Decision-Making in Pro..:

Dickson, S.P. ; Haaland, B. ; Mallinckrodt, C.H....
The Journal of Prevention of Alzheimer's Disease. , 2024

Link: https://doi.org/10.14283..

2

Evaluation of Clinical Meaningfulness of Fortasyn Connect i..:

Dickson, S.P. ; Solomon, A. ; Kivipelto, M....
The Journal of Prevention of Alzheimer's Disease. , 2024

Link: https://doi.org/10.14283..

3

'Time Saved' As a Demonstration of Clinical Meaningfulness ..:

Dickson, S.P. ; Wessels, A.M. ; Dowsett, S.A....
The Journal Of Prevention of Alzheimer's Disease. , 2023

Link: https://doi.org/10.14283..

4

Phase 2 Study Design and New Data from the Phase 1 SAD/MAD ..:

Detke, Michael ; Sabbagh, Marwan ; Holsinger, Leslie J...
Alzheimer's & Dementia. 19 (2023) S24 - p. , 2023

Link: https://doi.org/10.1002/..

5

Investigating Partially Discordant Results in Phase 3 Studi..:

Mallinckrodt, C. ; Tian, Y. ; Aisen, P.S....
The Journal Of Prevention of Alzheimer's Disease. , 2023

Link: https://doi.org/10.14283..

6

Two Randomized Phase 3 Studies of Aducanumab in Early Alzhe..:

Budd Haeberlein, S. ; Aisen, P.S. ; Barkhof, F....
The Journal of Prevention of Alzheimer's Disease. , 2022

Link: https://doi.org/10.14283..

7

Aligning Estimators With Estimands in Clinical Trials: Putt..:

Mallinckrodt, C. H. ; Bell, J. ; Liu, G....
Therapeutic Innovation & Regulatory Science. 54 (2020) 2 - p. 353-364 , 2020

Link: https://doi.org/10.1007/..

8

Aligning Estimators With Estimands in Clinical Trials: Putt..:

Mallinckrodt, C. H. ; Bell, J. ; Liu, G....
Therapeutic Innovation & Regulatory Science. , 2019

Link: https://doi.org/10.1177/..

9

Efficacy and safety of continuous every-2-week dosing of ix..:

Langley, R.G. ; Papp, K. ; Gooderham, M....
British Journal of Dermatology. 178 (2018) 6 - p. 1315-1323 , 2018

Link: https://doi.org/10.1111/..

10

Recent Developments in the Prevention and Treatment of Miss..:

Mallinckrodt, C. ; Roger, J. ; Chuang-Stein, C....
Therapeutic Innovation & Regulatory Science. 48 (2014) 1 - p. 68-80 , 2014

Link: https://doi.org/10.1177/..

11

A structured framework for assessing sensitivity to missing..:

Mallinckrodt, C.H. ; Lin, Q. ; Molenberghs, M.
Pharmaceutical Statistics. 12 (2012) 1 - p. 1-6 , 2012

Link: https://doi.org/10.1002/..

12

A structured approach to choosing estimands and estimators ..:

Mallinckrodt, C. H. ; Lin, Q. ; Lipkovich, I..
Pharmaceutical Statistics. 11 (2012) 6 - p. 456-461 , 2012

Link: https://doi.org/10.1002/..

13

The Enrichment Window Approach as a Means of Dealing with P..:

Mallinckrodt, C H ; Prucka, W R
Clinical Pharmacology & Therapeutics. 88 (2010) 5 - p. 592-594 , 2010

Link: https://doi.org/10.1038/..

14

The impact of analytic method on interpretation of outcomes..:

Prakash, A. ; Risser, R. C. ; Mallinckrodt, C. H.
International Journal of Clinical Practice. 62 (2008) 8 - p. 1147-1158 , 2008

Link: https://doi.org/10.1111/..

15

P.2.c.027 The relevance of treating painful somatic symptom..:

Wise, T.N. ; Meyers, A.L. ; Desaiah, D....
European Neuropsychopharmacology. 17 (2007) - p. S356 , 2007

Link: https://doi.org/10.1016/..